Buyline Blog

HEALTHCARE INDUSTRY INFORMATION AND INSIGHT FROM MD BUYLINE EXPERT ANALYSTS

Posts Tagged ‘cancer’

A Small “Scale” With A Big Future

By
September 4, 2012

Researchers at the Kavli Nanoscience Institute at the California Institute of Technology in Pasadena, California have teamed up with researchers [...] Read More »

Worried It’s Skin Cancer? There’s an App for that

By
July 26, 2012

Worried that unusual looking spot may be skin cancer? Put your fears at ease. Researchers at the University of Michigan [...] Read More »

Making Colonoscopy Pay

By
January 19, 2012

I was going through the MD Buyline database and found that endoscopy technology costs have been increasing at a rate [...] Read More »

Nanoshells in Cancer Therapy

By
August 9, 2011

Gold nanoshells are hollow structures that have been previously used for diagnostic tests. Along with their small size, gold nanoshells have a unique characteristic that allows them to be used as a therapeutic tool for cancer. The combination of a gold shell and hollow sphere gives them the ability to absorb near infrared light. The light is then converted to heat energy, which selectively destroys cancer cells from within. Read More »

By
July 5, 2011

Chemotherapy has been in use as a treatment for cancer since the early 20th century. Since then, it has grown to a $42 billion world market. Electrically-enhanced chemotherapy uses a pulsed electrical field to increase the cell membrane’s permeability. This allows the anticancer drug molecules that previously could not pass cells’ membranes to be absorbed directly in to the tumor. Read More »

Electrically – Enhanced Chemotherapy – Simple and Effective

By
July 5, 2011

Chemotherapy has been in use as a treatment for cancer since the early 20th century. Since then, it has grown to a $42 billion world market. Electrically-enhanced chemotherapy uses a pulsed electrical field to increase the cell membrane's permeability. This allows the anticancer drug molecules that previously could not pass cells membranes to be absorbed directly in to the tumor. Read More »

19% Increase for Breast Reconstruction, CMS Shows Support

By
June 23, 2011

A 19% increase in reimbursement for DRG 585 is pretty exciting, especially if your inpatient surgery department is performing open biopsies, local excisions, or reconstruction surgeries of the breast for 2011. In the last three years, DRG 585 (Breast Biopsy, Local Excision & Other Breast Procedures WO CC/MCC) has seen a 25% increase in reimbursement. Read More »

Oncology: Optical Biopsy Sheds Light on Cancer

By
April 14, 2011

The use of light as a medical diagnostic modality has been evolving since the pulse oximeter was first invented. The recent FDA approval of the optical coherence tomography imaging system (OCTIS) has taken the use of light as a diagnostic tool another step. OCTIS is designed to use multiple wavelengths of light to provide magnified cross-sectional images of a suspicious pathology. This, combined with its 1-mm catheter, will enable it to be a viable tool for lung and GI tract cancers. Read More »

Cancer ID in Five Minutes? Read on

By
March 9, 2011

Using light to identify a pathology is not a new concept. Several companies already have systems on the market that use either near-infrared (NIR), optical coherence tomography (OCT), or multimodal hyperspectral imaging (MHI) to diagnose vulnerable plaque or cancer. What makes NIVI technology unique is the use of pulse light to vibrate the tumor cells. This allows the technology to identify the composition of the cell at the molecular level along with a magnified image, resulting in a color image that distinguishes healthy from cancerous tissue. Read More »

PET = Personalized Cancer Therapy

By
January 31, 2011

Clinical trials support the advantages of using PET technology for determining the effectiveness of a therapy. One study demonstrated that PET has 95.9% accuracy in restaging cancer for patients after a first-line therapy, revealing that PET is very effective in grading tumors and measuring its tissue response to treatment. Read More »